Senior Vice President
Alnylam Pharmaceuticals
Cambridge, Massachusetts
Gabriel Robbie is Senior Vice President and Head of Clinical Pharmacology and Pharmacometrics at Alnylam. In this role, he is responsible for establishing and championing model based drug development to guide dose selection and clinical pharmacology strategy at Alnylam.
Prior to joining Alnylam, Dr. Robbie was Senior Director at MedImmune, Gaithersburg, and Associate Director in clinical pharmacology at AstraZeneca, Wilmington, Delaware. Prior to joining industry, he was at the U.S. Food & Drug Administration’s Office of Clinical Pharmacology.
Disclosure information not submitted.
Monday, October 17, 2022
9:30 AM – 10:00 AM ET